LC
Laura Coates
University of Leeds, University of Oxford, London School of Hygiene & Tropical Medicine, University of Liverpool
Research areas: Medicine · Rheumatology · Spondyloarthritis Studies and Treatments · Psoriasis: Treatment and Pathogenesis · Rheumatoid Arthritis Research and Therapies
0000-0002-4756-663X
Employment
-
University of Leeds NIHR Clinical Lecturer2012 - Present
Education
- 2008 - 2010
- 2007 - 2011
-
University of Liverpool MBChB1998 - 2003
Projects & Funding
Projects & funding information is unavailable.
Publications (395)
- Sustained Inhibition of Structural Damage Progression and Improvements in Disease Activity With Guselkumab in Biologic‐Naïve Participants with Active and Erosive Psoriatic Arthritis: Results Through Week 48 of the Phase 3b Randomized, Double‐Blind, Place… Save
- Bimekizumab efficacy across GRAPPA domains to 3 years in patients with psoriatic arthritis: a post hoc analysis of two phase 3 studies Save
- Ixekizumab With Tirzepatide Achieved Greater Disease Control Than Ixekizumab Alone in Adults With Psoriatic Arthritis and Overweight or Obesity: Results From a Randomized Clinical Trial Save
- Going beyond cycling versus swapping for treatment sequencing in psoriatic arthritis Save
- Psoriatic arthritis digital phenotyping and inflammation drivers (PDPID) study: protocol for an international multicentre prospective cohort Save
- Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors: 52-week safety and efficacy from the phase III BE COMPLETE study and its open-label extension BE VITAL Save
- Effects of Guselkumab on Structural Damage Progression in Patients with Active Psoriatic Arthritis Save
- Efficacy and safety of upadacitinib in patients with psoriatic arthritis and exposure to one anti-TNF: post hoc analysis of SELECT-PsA 2 Save
- Further Validation of a Questionnaire to Assess Flare in Psoriatic Arthritis: Determination of Cutoff and Longitudinal Change Save
- Psoriatic arthritis and obesity: a review of clinical burden and considerations for comprehensive care Save
- Progression from oligoarticular to polyarticular psoriatic arthritis and apremilast as a disease modifier: Novel insights from FOREMOST Save
- “I am struggling to find an explicit task”—a midterm evaluation of patient research partner involvement in HIPPOCRATES translational research Save
- Bimekizumab safety and efficacy in patients with psoriatic arthritis: 3-year results from two phase 3 studies Save
- Celebrating 50 years of spondyloarthritis Save
- Control of Inflammation and Sustained Improvements in Patient‐Reported Outcomes in Patients With Psoriatic Arthritis: Bimekizumab Two‐Year Results From Two Phase 3 Studies Save
- Composite and pragmatic measures in psoriatic arthritis: bridging trials and clinical feasibility Save
- Validity and Psychometric Properties of 3 and 4 Visual Analog Scale in Participants With Psoriatic Arthritis Treated With Guselkumab Save
- Cohort Study on Drug Survival and Tolerability of Adalimumab Biosimilar Transitioning: Pharmaceutical Properties Do Matter Save
- A retrospective observational study of effectiveness of sequential biologic and targeted synthetic DMARDs in psoriatic arthritis in the UK Save
- Comment on: Key factors contributing to gender inequity in global rheumatology awards: a global survey analysis: reply Save